Breaking News Instant updates and real-time market news.

IBM

IBM

$159.50

-2.72 (-1.68%)

, PFE

Pfizer

$31.74

-0.4 (-1.24%)

12:52
12/01/16
12/01
12:52
12/01/16
12:52

IBM, Pfizer announce collaboration on immuno-oncology research

IBM (IBM) Watson Health and Pfizer (PFE) announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer's research in immuno-oncology, an approach to cancer treatment that uses the body's immune system to help fight cancer. Mikael Dolsten, President, Pfizer Worldwide Research & Development, said, "With the incredible volume of data and literature available in this complex field, we believe that tapping into advanced technologies can help our scientific experts more rapidly identify novel combinations of immune-modulating agents. We are hopeful that by leveraging Watson's cognitive capabilities in our drug discovery efforts, we will be able to bring promising new immuno-oncology therapeutics to patients more quickly."

IBM

IBM

$159.50

-2.72 (-1.68%)

PFE

Pfizer

$31.74

-0.4 (-1.24%)

  • 01

    Dec

  • 04

    Dec

IBM IBM
$159.50

-2.72 (-1.68%)

11/10/16
BOFA
11/10/16
UPGRADE
BOFA
Buy
IBM upgraded to Buy from Neutral at BofA/Merrill
11/10/16
11/10/16
UPGRADE
Target $185

Buy
IBM upgraded to Buy on earnings growth at BofA/Merrill
As previously reported, BofA/Merrill upgraded IBM to Buy from Neutral and raised its price target to $185 from $170. Analyst Wamsi Mohan expects 2017 profits to grow as earnings have stabilized and negative revisions are unlikely and expects tailwinds from moderating pace of investments and savings from restructuring efforts. Further, the analyst expects IBM transnational revenues to recovery driven by the mainframe cycle in 2017 and the adoption of a Hybrid cloud model. Mohan said IBM is the most under owned tech named by large-cap US fund managers and provides upside from accumulation.
11/10/16
11/10/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Priceline (PCLN) upgraded to Buy from Hold at Stifel while the firm upgraded Expedia (EXPE) to Hold from Sell. 2. IBM (IBM) upgraded to Buy from Neutral at BofA/Merrill with analyst Wamsi Mohan expecting 2017 profits to grow as earnings have stabilized and negative revisions are unlikely and expects tailwinds from moderating pace of investments and savings from restructuring efforts. 3. L-3 Communications (LLL) and Northrop Grumman (NOC) upgraded to Overweight from Equal Weight at Barclays while the firm upgraded Lockheed Martin (LMT) to Equal Weight from Underweight. 4. Microsoft (MSFT) upgraded to Neutral from Underweight at Atlantic Equities. 5. Novartis (NVS) upgraded to Buy from Hold at Argus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/01/16
JEFF
12/01/16
NO CHANGE
Target $125
JEFF
Underperform
IBM likely decline in earnings not reflected in stock, says Jefferies
Jefferies analyst James Kisner said his analysis suggests that IBM's software service/support revenue may have declined 4% in calendar 2015 and could also be falling organically this year, which he calls "particularly troubling" in light of steep declines in transactional sales. Continuing annual declines of roughly 3% in the Software business could drive a 5-6% headwind to EPS annually through 2020, Kisner tells investor. The analyst cut his EPS estimates for IBM based on reduced expectations for the Software business and expectations for 2017 IP Income to be below consensus. Kisner reiterates his Underperform rating and $125 price target on IBM shares.
PFE Pfizer
$31.74

-0.4 (-1.24%)

11/02/16
ARGS
11/02/16
DOWNGRADE
ARGS
Hold
Pfizer downgradedon weaker outlook at Argus
As noted earlier, Argus downgraded Pfizer to Hold from Buy. Analyst Jacob Kilstein cited "recent pipeline setbacks, prospects for increased competition, and management's decision to shelve its business separation plan" as reasons for the downgrade.
11/02/16
11/02/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Pfizer (PFE) downgraded to Hold from Buy at Argus and to Market Perform from Outperform at BMO Capital. 2. BP (BP) downgraded to Hold from Buy at Societe Generale. 3. Corning (GLW) downgraded to Buy from Conviction Buy at Goldman with analyst Doug Clark saying the restocking phase of glass/TV cyclical recovery is now "well understood and largely behind us." 4. Adeptus Health (ADPT) downgraded to Underperform from Buy at BofA/Merrill, to Hold from Buy at Jefferies, and to Equal Weight from Overweight at Stephens. 5. Brookdale Senior Living (BKD) downgraded to Underperform from Neutral at BofA/Merrill, to Market Perform from Outperform at Wells Fargo, and to Outperform from Top Pick at RBC Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/29/16
LEHM
11/29/16
UPGRADE
Target $38
LEHM
Overweight
Pfizer upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Geoff Meacham upgraded Pfizer to Overweight and raised its price target to $38 from $37. Meacham sees a greater likelihood that Pfizer will be able to access its cash overseas under the new administration, which could be used to acquire growth assets and return capital to shareholders.
11/29/16
11/29/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pfizer (PFE) upgraded to Overweight from Equal Weight at Barclays with analyst Geoff Meacham saying he sees a greater likelihood that Pfizer will be able to access its cash overseas under the new administration, which could be used to acquire growth assets and return capital to shareholders. 2. Comerica (CMA) upgraded to Outperform from Market Perform at Keefe Bruyette. 3. Tractor Supply (TSCO) upgraded to Buy from Neutral at Northcoast with analyst Chuck Cerankosky saying he expects the company to benefit from colder weather and the improving US economy and said product assortments and promotions have also been adjusted to the new economics of the energy patch and its impact on this company's customers. 4. Del Frisco's (DFRG) upgraded to Outperform from Neutral at Credit Suisse with analyst Jason West saying it is a key beneficiary of improved high-end consumer and corporate spending. 5. Veracyte upgraded to Buy from Neutral at Janney Capital with analyst Paul Knight saying the company's "disciplined test development, commercialization, and reimbursement processes" insulate it from a number of problems plaguing the pharma sector. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

KFRC

Kforce

$25.50

0.3 (1.19%)

05:15
02/24/17
02/24
05:15
02/24/17
05:15
Downgrade
Kforce rating change  »

Kforce downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$120.70

1.27 (1.06%)

05:14
02/24/17
02/24
05:14
02/24/17
05:14
Upgrade
Intuit rating change  »

Intuit upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$24.66

-0.12 (-0.48%)

05:13
02/24/17
02/24
05:13
02/24/17
05:13
Downgrade
HP Enterprise rating change  »

HP Enterprise downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$38.58

-2.68 (-6.50%)

05:13
02/24/17
02/24
05:13
02/24/17
05:13
Downgrade
Wayfair rating change  »

Wayfair downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTGC

Hercules Capital

$14.94

-0.49 (-3.18%)

05:12
02/24/17
02/24
05:12
02/24/17
05:12
Downgrade
Hercules Capital rating change  »

Hercules Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVR

Invesco Mortgage

$15.57

0.08 (0.52%)

05:12
02/24/17
02/24
05:12
02/24/17
05:12
Downgrade
Invesco Mortgage rating change  »

Invesco Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

REG

Regency Centers

$70.95

0.94 (1.34%)

, EQY

Equity One

$31.91

0.39 (1.24%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Equity One to host special shareholder meeting »

Special Shareholder…

REG

Regency Centers

$70.95

0.94 (1.34%)

EQY

Equity One

$31.91

0.39 (1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

MMM

3M

$187.19

1.15 (0.62%)

, BIOL

BIOLASE

$1.50

-0.02 (-1.32%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Chicago Dental Society to hold a meeting »

Chicago Dental Midwinter…

MMM

3M

$187.19

1.15 (0.62%)

BIOL

BIOLASE

$1.50

-0.02 (-1.32%)

COF

Capital One

$93.41

0.52 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$42.51

-1.83 (-4.13%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Rio Tinto management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 26

    Feb

EQY

Equity One

$31.91

0.39 (1.24%)

, REG

Regency Centers

$70.95

0.94 (1.34%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Regency Centers to host special shareholder meeting »

Special Shareholder…

EQY

Equity One

$31.91

0.39 (1.24%)

REG

Regency Centers

$70.95

0.94 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

CASM

CAS Medical

$1.48

-0.01 (-0.67%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
CAS Medical management to meet with Craig Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

PBNC

Paragon Commercial

$50.50

-0.35 (-0.69%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Paragon Commercial management to meet with Sandler O'Neill »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

SC

Santander Consumer

$14.33

-0.12 (-0.83%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Santander Consumer management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

ELNK

EarthLink

$5.85

0.04 (0.69%)

, WIN

Windstream

$7.29

0.07 (0.97%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Windstream to host special shareholder meeting »

Virtual Special…

ELNK

EarthLink

$5.85

0.04 (0.69%)

WIN

Windstream

$7.29

0.07 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 01

    Mar

  • 06

    Mar

GIS

General Mills

$60.78

0.19 (0.31%)

, TSN

Tyson Foods

$62.82

-0.4 (-0.63%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
The Consumer Analyst Group of New York to hold a conference »

2017 CAGNY Conference is…

GIS

General Mills

$60.78

0.19 (0.31%)

TSN

Tyson Foods

$62.82

-0.4 (-0.63%)

TWNK

Hostess Brands

$15.78

0.31 (2.00%)

MJN

Mead Johnson

$87.61

0.11 (0.13%)

K

Kellogg

$74.80

0.31 (0.42%)

MDLZ

Mondelez

$44.89

0.24 (0.54%)

INGR

Ingredion

$122.28

1.66 (1.38%)

LNCE

Snyder's-Lance

$39.60

0.17 (0.43%)

SYY

Sysco

$52.89

0.14 (0.27%)

JNJ

Johnson & Johnson

$120.90

2.18 (1.84%)

SJM

J.M. Smucker

$140.83

0.1 (0.07%)

MO

Altria Group

$74.46

0.86 (1.17%)

CPB

Campbell Soup

$59.06

-0.11 (-0.19%)

PEP

PepsiCo

$109.54

0.13 (0.12%)

CLX

Clorox

$135.83

-0.09 (-0.07%)

BG

Bunge

$80.05

0.61 (0.77%)

PG

Procter & Gamble

$91.13

-0.31 (-0.34%)

DANOY

Danone

$13.34

0.13 (0.98%)

SPB

Spectrum Brands

$137.26

0.97 (0.71%)

KO

Coca-Cola

$41.66

0.06 (0.14%)

IFF

International Flavors

$125.14

2.51 (2.05%)

STZ

Constellation Brands

$153.60

-6.6 (-4.12%)

NSRGY

Nestle

$74.20

0.4 (0.54%)

CHD

Church & Dwight

$49.62

-0.07 (-0.14%)

UN

Unilever; also tag UL

$46.58

-0.17 (-0.36%)

CL

Colgate-Palmolive

$74.44

0.95 (1.29%)

NWL

Newell Brands

$46.80

-0.26 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 27

    Feb

  • 09

    Mar

  • 14

    Mar

  • 15

    Mar

  • 19

    Mar

  • 27

    Mar

  • 09

    May

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
CLSA to hold a forum »

Japan Forum is being held…

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
CLSA financial tech analyst holds an analyst/industry conference call »

Financial Technology…

AGN

Allergan

$246.33

0.71 (0.29%)

, EDGE

Edge Therapeutics

$10.00

-0.27 (-2.63%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
American Heart Association to hold a conference »

International Stroke…

AGN

Allergan

$246.33

0.71 (0.29%)

EDGE

Edge Therapeutics

$10.00

-0.27 (-2.63%)

AMGN

Amgen

$174.01

1.4 (0.81%)

ATRC

AtriCure

$17.35

0.13 (0.75%)

BMY

Bristol-Myers

$55.77

0.42 (0.76%)

DNA

Bought by RHHBY

MDCO

The Medicines Co.

$51.84

-0.38 (-0.73%)

MDT

Medtronic

$80.74

1.12 (1.41%)

MRK

Merck

$65.85

0.56 (0.86%)

PH

Parker-Hannifin

$153.70

-2.16 (-1.39%)

PTLA

Portola Pharmaceuticals

$32.16

0.02 (0.06%)

Q

QuintilesIMS

$78.12

0.77 (1.00%)

SSNLF

Samsung

SAY

Satyam

TWTR

Twitter

$16.03

-0.05 (-0.31%)

WTKWY

Wolters Kluwer

$40.39

0.502 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 02

    Mar

  • 07

    Mar

  • 08

    Mar

  • 09

    Mar

  • 15

    Mar

  • 17

    Mar

  • 19

    Mar

  • 21

    Mar

  • 28

    Mar

  • 01

    Apr

  • 04

    May

  • 10

    May

  • 27

    May

  • 14

    Jun

  • 24

    Jun

  • 19

    Jul

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Wells Fargo housing analyst holds an analyst/industry conference call »

Senior Housing Analyst…

NVO

Novo Nordisk

$35.78

0.53 (1.50%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Novo Nordisk management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 07

    Mar

KAR

KAR Auction

$44.50

-0.3 (-0.67%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
KAR Auction management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 13

    Mar

  • 14

    Mar

  • 15

    Mar

04:55
02/24/17
02/24
04:55
02/24/17
04:55
General news
Consumer Sentiment Index to be reported at 10:00 »

February Consumer…

04:55
02/24/17
02/24
04:55
02/24/17
04:55
General news
New Home Sales to be reported at 10:00 »

January New Home Sales…

VWDRY

Vestas

$25.08

0.175 (0.70%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Vestas management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

HSIC

Henry Schein

$171.92

-0.72 (-0.42%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Henry Schein management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.